Premium
Clinicopathological profile of primary bronchogenic carcinoma treated in a tertiary care hospital of western Nepal
Author(s) -
CHANDRASHEKHAR Thummalahally Sreeramareddy,
BINU Valsala Sreekumaran,
VADIVELU Gnanaprakasam,
MALLIK Singaraju,
KURIEN Renju,
JOSHI Hari Shankar
Publication year - 2006
Publication title -
asia‐pacific journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.73
H-Index - 29
eISSN - 1743-7563
pISSN - 1743-7555
DOI - 10.1111/j.1743-7563.2006.00046.x
Subject(s) - medicine , interquartile range , bronchogenic carcinoma , incidence (geometry) , carcinoma , adenocarcinoma , cancer , small cell carcinoma , lung cancer , gastroenterology , surgery , physics , optics
Abstract Background: Bronchogenic carcinoma is the most common cancer in Nepal. There is no information available about the incidence and clinicopathological features of bronchogenic carcinoma from Nepal. We aimed to study the clinicopathological features of primary bronchogenic carcinoma treated in a tertiary care hospital. Methods: A retrospective case‐series analysis of 136 cases of primary bronchogenic carcinoma treated between September 2001 and August 2005 in a tertiary care hospital of western Nepal was performed. Results: The median age of the male and female patients was 67 (interquartile range 60, 71.75) and 66 (interquartile range 60, 70) years, respectively. The maximum number of patients was in the 60–69 year age group. One‐hundred and thirteen (83.1%) of these patients were smokers. Among the male patients, 83.3% (60/72) were smokers and females 82.8% (53/64) were smokers. The male to female ratio of the patients was 1.1: 1. The most common histological type was squamous‐cell carcinoma (51.5%), followed by small‐cell carcinoma (17.6%) and adenocarcinoma (8.1%). Ninety‐eight (72.1%) patients were diagnosed in late stages of the disease (IIIb and IV). Conclusion: The clinicopathological features are in accordance with reports from other studies. The results of the present study indicate that bronchogenic carcinoma has a higher average age incidence, higher proportion of female patients and higher proportion of diagnosis of the disease in late stages. The higher rate of bronchogenic carcinoma among females indicates scope for further research into risk factors. Intervention measures for prevention and early diagnosis of bronchogenic carcinoma are to be undertaken.